Recursion Pharmaceuticals, Inc. (BMV:RXRX)
Mexico flag Mexico · Delayed Price · Currency is MXN
110.00
-2.00 (-1.79%)
At close: Aug 5, 2025

Arcadium Lithium Statistics

Total Valuation

BMV:RXRX has a market cap or net worth of MXN 42.94 billion. The enterprise value is 34.78 billion.

Market Cap42.94B
Enterprise Value 34.78B

Important Dates

The last earnings date was Friday, August 8, 2025.

Earnings Date Aug 8, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 427.31M
Shares Outstanding n/a
Shares Change (YoY) +57.85%
Shares Change (QoQ) +3.62%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 416.17M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 35.25
PB Ratio 2.48
P/TBV Ratio 5.51
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -2.84
EV / Sales 28.83
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -4.68

Financial Position

The company has a current ratio of 3.58, with a Debt / Equity ratio of 0.10.

Current Ratio 3.58
Quick Ratio 3.33
Debt / Equity 0.10
Debt / EBITDA n/a
Debt / FCF -0.22
Interest Coverage -302.76

Financial Efficiency

Return on equity (ROE) is -86.34% and return on invested capital (ROIC) is -48.30%.

Return on Equity (ROE) -86.34%
Return on Assets (ROA) -39.08%
Return on Invested Capital (ROIC) -48.30%
Return on Capital Employed (ROCE) -57.08%
Revenue Per Employee 1.52M
Profits Per Employee -15.30M
Employee Count800
Asset Turnover 0.06
Inventory Turnover n/a

Taxes

In the past 12 months, BMV:RXRX has paid 320,589 in taxes.

Income Tax 320,589
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 37.09
Average Volume (20 Days) 4,926

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 4.11

Income Statement

In the last 12 months, BMV:RXRX had revenue of MXN 1.22 billion and -12.24 billion in losses. Loss per share was -34.02.

Revenue1.22B
Gross Profit -8.17B
Operating Income -12.25B
Pretax Income -12.24B
Net Income -12.24B
EBITDA -11.06B
EBIT -12.25B
Loss Per Share -34.02
Full Income Statement

Balance Sheet

The company has 9.90 billion in cash and 1.66 billion in debt, giving a net cash position of 8.24 billion.

Cash & Cash Equivalents 9.90B
Total Debt 1.66B
Net Cash 8.24B
Net Cash Per Share n/a
Equity (Book Value) 17.33B
Book Value Per Share 40.05
Working Capital 7.98B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.22 billion and capital expenditures -204.46 million, giving a free cash flow of -7.43 billion.

Operating Cash Flow -7.22B
Capital Expenditures -204.46M
Free Cash Flow -7.43B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -1,005.81%
Pretax Margin -1,004.88%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BMV:RXRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -57.85%
Shareholder Yield n/a
Earnings Yield -28.51%
FCF Yield -17.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BMV:RXRX has an Altman Z-Score of 0.32 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.32
Piotroski F-Score 1